Status:

RECRUITING

Mechanisms of Pregnancy Vascular Adaptations

Lead Sponsor:

University of Wisconsin, Madison

Collaborating Sponsors:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Pre-Eclampsia

Vascular Diseases

Eligibility:

FEMALE

18-40 years

Brief Summary

The investigators will collect omental tissue (research surgical excision) and placental tissue (standard of care clinical delivery) from both preeclamptic and non-preeclamptic women during their c-se...

Detailed Description

Trial Design: The study is a comparison of two cohorts, those with and without preeclampsia during pregnancy. The team plans to investigate role of FABP4, PFAS and AT2 in modulation of vascular functi...

Eligibility Criteria

Inclusion

  • female
  • Minimum age: 18
  • Maximum age: 40
  • Singleton births
  • Minimum gestational age at consent: 28 weeks, 0 days
  • Maximum gestational age at consent: 41 weeks, 0 days
  • Undergoing caesarean section, either planned or otherwise with or without trial of labor

Exclusion

  • Preexisting hypertension treated by antihypertensive agents during the prenatal period. This will not include treatment of severe hypertension by antihypertensive or use of magnesium sulfate after the patient is hospitalized for the diagnosis of preeclampsia.
  • Any major fetal structural anomalies or aneuploidies
  • Preexisting conditions like pre-gestational type I or type II diabetes mellitus, pre-pregnancy kidney disease with increased serum creatinine above 1.2 mg/dL, or other underlying blood vessel problems like systemic lupus erythematosus or other autoimmune conditions with evidence of pre-pregnancy proteinuria or hypertension.
  • Undergoing cesarean section for placental abruption or bleeding complications.
  • Singleton gestation not within 36 weeks, 0 days and 41 weeks, 0 days gestational age at the time of enrollment (delivery)

Key Trial Info

Start Date :

November 20 2018

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

April 1 2027

Estimated Enrollment :

114 Patients enrolled

Trial Details

Trial ID

NCT03806283

Start Date

November 20 2018

End Date

April 1 2027

Last Update

August 22 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UnityPoint Health-Meriter Hospital

Madison, Wisconsin, United States, 53715